PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Nipro Launches D2F™ Glass Vials Powered by Stevanato Group’s EZ-fill® Technology

Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, is proud to announce the launch of its innovative D2F™ (Direct-to-Fill) glass vials.

These vials, featuring Stevanato Group’s advanced EZ-fill® technology, offer a high-quality ready-to-use (RTU) solution designed to meet the rigorous standards and increasing requirements of the pharmaceutical industry.

Key Features of D2F™ Glass Vials

Direct-to-Fill Technology:
D2F™ glass vials are washed, depyrogenated, packaged in nest & tub formats, and sterilised providing a seamless RTU solution. Pharmaceutical companies can integrate these vials directly into their aseptic fill-finish processes.

Optimised for Fill-Finish Lines:
Developed in collaboration with leading machine suppliers, D2F™ vials are compatible with a wide range of fill-finish lines, ensuring easy and quick integration, thus speeding up operations.

Increased Stability & Cost Efficiency:
D2F™ vials’ nest & tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling. This results in improved mechanical durability, lower downtime, and fewer rejections during final inspections, ultimately contributing to more stable and cost-efficient fill-finish operations.

“We are excited to introduce D2F™ glass vials, offering a reliable and efficient RTU packaging solution that addresses the evolving needs of the pharmaceutical industry. These vials exemplify our mission to delivering trust with premium primary pharma packaging solutions.” – Stephan Arnold, CEO of Nipro PharmaPackaging.

“The collaboration with Nipro represents another important milestone for Stevanato Group’s EZ-fill® pre-sterilized platform,” said Mauro Stocchi, Chief Business Officer at Stevanato Group. “Nipro’s adoption of the EZ-fill® platform further validates Stevanato Group’s technological leadership and strengthens our market position in secondary packaging for aseptic manufacturing. The EZ-fill® platform is an increasingly reliable, scalable, and cost-effective solution and industry-validated technology, and we believe it will become a widely recognized standard in the industry.” – Stevanato.

For more information on D2F™ glass vials, visit https://www.nipro-group.com

About Nipro:
Nipro PharmaPackaging specialises in the development and manufacturing of advanced pharmaceutical packaging products and complete packaging solutions for early-stage drug development or the enhancement of packaging solutions for existing pharmaceutical drugs.

Nipro PharmaPackaging is part of Nipro Corporation Japan, a leading global healthcare company founded in 1954 in Osaka with close to 40,000 colleagues worldwide. Nipro Corporation serves the medical device, pharmaceutical, pharma packaging and regenerative medicine sectors.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026